Review articlePublished 16 Dec 2015
A Novel SCN9A Gene Mutation in a Patient with Carbamazepine-ResistantParoxysmal Extreme Pain Disorder
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Paroxysmal extreme pain disorder is an autosomal dominant disorder caused by mutation of the SCN9A gene. In most cases, the pain is relieved by carbamazepine. We report on a novel SCN9A mutation associated with carbamazepine-resistant. The proband was a 7-month-old child who suffered from typical attacks from birth onwards. Sequencing of SCN9A revealed a heterozygous c.4880T>G substitution. Identification of this novel mutation and characterization of the associated carbamazepine-resistant phenotype may facilitate diagnosis and drug development.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pediatric Neurological Disorders
- SubjectNeuroscience & Neurology
- SubjectPaediatrics & Neonatology
- BylineArticles whose byline prints “Huin V”
- BylineArticles whose byline prints “Cuvellier J”
- BylineArticles whose byline prints “Genet A”
- BylineArticles whose byline prints “Dhaenens C”
- BylineArticles whose byline prints “Vallée L”
- BylineArticles whose byline prints “Sablonnière B”